Nemni, Raffaello

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

Saresella, M., La Rosa, F., Piancone, F., Zoppis, M., Marventano, I., Calabrese, E., Rainone, V., Nemni, R., Mancuso, R., & Clerici, M. (2016) · Molecular Neurodegeneration

Inflammasome and immune disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 489

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Lawlor, B., Segurado, R., Kennelly, S., Olde Rikkert, M. G. M., Howard, R., Pasquier, F., Börjesson-Hanson, A., Tsolaki, M., Lucca, U., Molloy, D. W., et al. (2018) · PLOS Medicine

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 193

Evaluating two group programmes of cognitive training in mild-to-moderate AD: is there any difference between a 'global' stimulation and a 'cognitive-specific' one?

Farina, E., Mantovani, F., Fioravanti, R., Pignatti, R., Chiavari, L., Imbornone, E., Olivotto, F., Alberoni, M., Mariani, C., & Nemni, R. (2006) · Aging & Mental Health

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 81

Efficacy of Recreational and Occupational Activities Associated to Psychologic Support in Mild to Moderate Alzheimer Disease: A Multicenter Controlled Study

Farina, E., Mantovani, F., Fioravanti, R., Rotella, G., Villanelli, F., Imbornone, E., Olivotto, F., Tincani, M., Alberoni, M., Petrone, E., et al. (2006) · Alzheimer Disease & Associated Disorders

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 56

Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD

Dyer, A. H., Murphy, C., Lawlor, B., Kennelly, S. P., Lawlor, B., Segurado, R., Kennelly, S., Olde Rikkert, M. G. M., Howard, R., Pasquier, F., et al. (2020) · Journal of the American Medical Directors Association

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 39

REST, a master regulator of neurogenesis, evolved under strong positive selection in humans and in non human primates

Mozzi, A., Guerini, F. R., Forni, D., Costa, A. S., Nemni, R., Baglio, F., Cabinio, M., Riva, S., Pontremoli, C., Clerici, M., et al. (2017) · Scientific Reports

Neurogenesis and neuroplasticity mechanismsGenetics and Neurodevelopmental Disorders

Cited by 28